Assertio Therapeutics Stock Forward View - Price Action Indicator
| ASRT Stock | USD 11.78 0.05 0.43% |
Assertio Stock outlook is based on your current time horizon.
At this time, The value of RSI of Assertio Therapeutics' share price is at 57. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Assertio Therapeutics, making its price go up or down. Momentum 57
Buy Extended
Oversold | Overbought |
Using Assertio Therapeutics hype-based prediction, you can estimate the value of Assertio Therapeutics from the perspective of Assertio Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Assertio Therapeutics after-hype prediction price | USD 11.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Assertio Therapeutics to cross-verify your projections. For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.Assertio Therapeutics Additional Predictive Modules
Most predictive techniques to examine Assertio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Assertio using various technical indicators. When you analyze Assertio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Assertio Therapeutics Volatility | Backtest Assertio Therapeutics | Information Ratio |
Assertio Therapeutics Trading Date Momentum
| On February 01 2026 Assertio Therapeutics was traded for 11.78 at the closing time. The top price for the day was 12.00 and the lowest listed price was 11.35 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.95% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Assertio Therapeutics to competition |
Other Forecasting Options for Assertio Therapeutics
For every potential investor in Assertio, whether a beginner or expert, Assertio Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Assertio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Assertio. Basic forecasting techniques help filter out the noise by identifying Assertio Therapeutics' price trends.Assertio Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Assertio Therapeutics stock to make a market-neutral strategy. Peer analysis of Assertio Therapeutics could also be used in its relative valuation, which is a method of valuing Assertio Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Assertio Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Assertio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Assertio Therapeutics shares will generate the highest return on investment. By undertsting and applying Assertio Therapeutics stock market strength indicators, traders can identify Assertio Therapeutics entry and exit signals to maximize returns.
Assertio Therapeutics Risk Indicators
The analysis of Assertio Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Assertio Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting assertio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.64 | |||
| Semi Deviation | 3.14 | |||
| Standard Deviation | 3.88 | |||
| Variance | 15.05 | |||
| Downside Variance | 11.49 | |||
| Semi Variance | 9.89 | |||
| Expected Short fall | (2.98) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Assertio Therapeutics
The number of cover stories for Assertio Therapeutics depends on current market conditions and Assertio Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Assertio Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Assertio Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Assertio Therapeutics Short Properties
Assertio Therapeutics' future price predictability will typically decrease when Assertio Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Assertio Therapeutics often depends not only on the future outlook of the potential Assertio Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assertio Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.4 M | |
| Cash And Short Term Investments | 100.1 M |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.